Inactive Instrument

Analyst Reco. Aerie Pharmaceuticals, Inc.

Equities

Citigroup Downgrades Aerie Pharmaceuticals to Neutral From Buy	22-08-29	MT
HC Wainwright Downgrades Aerie Pharmaceuticals to Neutral From Buy	22-08-24	MT
Truist Securities Downgrades Aerie Pharmaceuticals to Hold From Buy, Raises Price Target to $15.25 From $13	22-08-23	MT
Wall Street Stabilizes Pre-Bell After Slump Fueled by Rate Hike Concerns	22-08-23	MT
Stifel Downgrades Aerie Pharmaceuticals to Hold From Buy	22-08-23	MT
Needham Downgrades Aerie Pharmaceuticals to Hold From Buy	22-08-23	MT
ANALYST RECOMMENDATIONS : Deere, Pioneer Natural Resources, Palon Alto Networks, Workday, Diamondback Energy...	22-08-23
Cantor Fitzgerald Cuts Aerie Pharmaceuticals to Neutral From Overweight, Price Target to $15.25 From $30	22-08-23	MT
Truist Securities Lowers Aerie Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating	22-08-01	MT
HC Wainwright Lowers Aerie Pharmaceuticals Price Target to $20 From $25, Buy Rating Kept	22-05-09	MT
Needham Adjusts Aerie Pharmaceuticals' Price Target to $14 from $22, Keeps Buy Rating	22-02-25	MT
Needham Adjusts Price Target on Aerie Pharmaceuticals to $22 From $24, Maintains Buy Rating	21-11-05	MT
AERIE PHARMACEUTICALS : Needham Adjusts Price Target on Aerie Pharmaceuticals to $24 From $26, Maintains Buy Rating	21-08-05	MT
AERIE PHARMACEUTICALS : Oppenheimer Adjusts Aerie Pharmaceuticals PT to $26 From $24, Maintains Outperform Rating	21-02-26	MT
AERIE PHARMACEUTICALS : HC Wainwright Adjusts Aerie Pharmaceuticals' Price Target to $29 from $31, Maintains Buy Rating	20-11-09	MT

No results for this search